Synthesis of vincaminic acid derivatives |
| I claim: 1. A process for the preparation of vincaminic acid derivatives of formula ##STR4## in ... |
|
Certain N-phenyl or N-pyridyl aza sulfonium salts |
| OF THE INVENTION More specifically, this invention provides an improved process for making ... |
|
Apparatus for treating finely divided materials with gaseous fluid |
| My invention aims to provide a method which does not present the aforementioned disadvantages and ... |
|
Flavoring compositions containing dialkyl-.alpha.,.beta.-diacyl succinates |
| What is claimed is: 1. A flavor composition comprising a flavor component and 0.0001% to 30% by ... |
|
Method of forming an image with photographic likeness on chocolate |
| It is an object of the present invention to economically create a quality photographic image with ... |
|
6-Acylamino-penam-3-carboxylic and 7-acylamino-3-cephem-4-carboxylic acids |
| We claim: 1. A compound of the formula I ##STR11## wherein the grouping -S-A- represents a radical ... |
|
Dry pesticidal compositions |
| What is claimed is: 1. A dry pesticidal composition of a toxicant useful for crops having a melting ... |
|
Amino acid solution for intravenous nutrition |
| OF THE PREFERRED EMBODIMENTS In the study leading to the present invention a rat whose small ... |
|
Warm two tone flavored dentifrice |
| I claim: 1. An anhydrous heat releasing fluoride dentifrice which generates heat in the mouth ... |
|
Toothpaste with zeolite polishing agent |
| We claim: 1. In an aqueous toothpaste composition having about 15-60% by weight polishing agent, ... |
|
|
Therapeutic substituted indole compounds and compositions thereof
| Details |
Inventors: Robertson, Alan D.; Martin, Graeme R.; Buckingham, Janet S.;
Assignee: Burroughs Wellcome Co. (Research Triangle Park, NC)
Primary Examiner: Lee; Mary C.
Assistant Examiner: Miltenberger; Lenora
Attorney, Agent or Firm: Brown; Donald, Nielsen; Lawrence A., Green; Hannah O.
The present invention is concerned with compounds of formula (I) ##STR1## wherein R, R.sup.1 and R.sup.2 are independently selected from hydrogen and C.sub.1-4 alkyl; R.sup.3 and R.sup.4 are independently selected from hydrogen, C.sub.1-6 alkyl (including cycloalkyl) and aryl (wherein the alkyl or aryl group, which latter includes benzyl, is optionally substituted by one or more atoms or groups independently selected from halogen, C.sub.1-4 alkyl and aryl), provided R.sup.3 benzyl or substituted benzyl when R.sup.4 =H; m is an integer of from 0 to 2; n is an integer of from 0 to 3; (W) is a group of formula (i), (ii), (iii), or (iv) ##STR2## wherein Y is selected from oxygen, methylene and >N--R.sup.5, where R.sup.5 is hydrogen, C.sub.1-4 alkyl, or benzyl, Z and Z' are independently selected from >C.dbd.O, >C.dbd.S and methylene, and the chiral center * in formula (i) or (ii) is in its (S) or (R) form or is a mixture thereof in any proportions; X is a group selected from aryl (including heteroaryl) xanthenyl dibenzofuranyl which group is optionally substituted; and salts and solvates thereof, the preparation of these compounds, pharmaceutical formulations containing them and their use in medicine, particularly in the treatment of migraine. |
|
DETAILED DESCRIPTION We claim: 1. A compound of formula (I) ##STR39## wherein R, R. sup. 1 and R. sup. 2 are independently selected from hydrogen and C. sub. 1-4 alkyl; R. sup. 3 and R. sup. 4 are independently selected from hydrogen, C. sub. 1-6 alkyl, C. sub. 3-6 cycloalkyl, aryl, and benzyl, wherein the alkyl, cycloalkyl, aryl or benzyl group is optionally substituted by one or more atoms or groups independently selected from halogen, C. sub. 1-4 alkyl and aryl, provided R. sup. 3 . noteq. benzyl or substituted benzyl when R. sup. 4 =H; m is an integer of from 0 to 2; n is an integer of from 0 to 3; (W) is a group of formula (i), (ii), (iii) or (iv) ##STR40## wherein, in formulae (i) and (ii), R. sup. 5 is hydrogen, C. sub. 1-4 alkyl or benzyl, and the chiral center *in formula (i) or (ii) is in its (S) or (R) form or is mixture thereof in any proportions; X is phenyl which group is optionally substituted by an atom or group selected from C. sub. 1-6 alkyl C. sub. 3-6 cycloalkyl phenyl C. sub. 1-4 alkoxy phenoxy alkylsulphonyl phenylsulphonyl halogen cyano carbamoyl alkylcarbamoyl dialkylcarbamoyl phenylcarbamoyl diphenylcarbamoyl carbamoylmethyl N-alkylcarbamoylmethyl N,N-dialkylcarbamoylmethyl N-phenylcarbamoylmethyl N,N-diphenylcarbamoylmethyl alkoylamino benzoylamino alkoylaminomethyl benzoylaminomethyl alkylsulphamino phenylsulphamino alkylsulphaminomethyl phenylsulphaminomethyl sulphamyl alkylsulphamyl dialkylsulphamyl phenylsulphamyl or diphenylsulphamyl the phenyl group(s) of phenyl-containing substituents being optionally substituted by halogen or C. sub. 1-4 alkoxy; or a salt or solvate thereof. 2. A compound of formula (I) as claimed in claim 1, or a salt or solvate thereof, in which (W) is (i) wherein Y=0, CH. sub. 2, or NR. sup. 5, Z=CO or CH. sub. 2 and Z'=CO, (W) is (ii) wherein Y=CH. sub. 2 or NR. sup. 5 and Z=Z'=CO, (W) is (iii) wherein Y=CH. sub. 2 or NR. sup. 5, Z=CO and Z'=CO or CH. sub. 2, or (W) is (iv) wherein Y=CH. sub. 2, Z=CO and Z'=CO or CH. sub. 2, and X is a phenyl ring substituted by an alkylcarbamoyl, alkoylamino, or alkylsulphamino group
|
| Related patents |
|
|
Methods of inhibiting ovarian dysgenesis, delayed puberty, or sexual infantilism
OF THE INVENTION The current invention concerns the discovery that a select group of 2-phenyl-3-aroylbenzothiophenes (benzothiophenes), those of formula I, are useful ...
|
|
|
Phenylvinyl morpholine compounds
What we claim is: 1. A morpholine derivative of the formula: ##STR17## wherein A stands for the trans vinylene radical and X stands for a phenyl radical which is ...
|
|
|
Method of reducing plant growth height using phenylalkylmorpholines
We claim: 1. A method of reducing the growth height in plants, which comprises allowing an effective amount of phenylalkylamine of the formula ##STR12## where the ...
|
|
|
Piperazine compounds
We claim: 1. A compound of formula (I) ##STR16## wherein R.sub.1 represents --COR.sub.4, --CO.sub.2 R.sub.4 or --COCO.sub.2 R.sub.4 (where R.sub.4 represents a hydrogen ...
|
|
|
Insecticidal heterocyclic compounds
What is claimed is: 1. A heterocyclic compound of the formula: ##STR59## wherein A represents 2-chloropyridin-5-yl or 2-chlorothiazol-5-yl; Z.sup.1 represents O; R.sup.2 ...
|
|
|
Self-locking cerebral electrical probe
In view of the foregoing objects, the instant invention contemplates a cerebral probe for stereoelectroencephalographic exploration which comprises a long, hollow, ...
|
|
|
Transvenous cardiovascular integrated lead anchoring sleeve, protector, and permanent lead introducer stop gap
The present invention overcomes the problems inherent in the prior art apparatus and techniques by employing a suturing sleeve which is permanently attached about the ...
|
|
|
Ear canal electrode
It is an object of this invention to provide a noninvasive external ear canal electrode with reduced electrical resistance and greater electrical sensitivity. It is a ...
|
|
|
Method of reducing the level of low density lipoproteins in the serum of a patient
What is claimed is: 1. A method for reducing the level of low density lipoproteins in the serum of a patient which comprises, administering human fibroblast interferon ...
|
|
|
7-acylamino-3-vinylcephalosporanic acid derivatives and processes for the preparation thereof
What we claim is: 1. A compound of the formula: R.sub.d.sup.1 --A.sup.14 --R.sup.e in which R.sub.d.sup.1 is aminopyridyl, protected aminopyridyl, aminopyrimidinyl or ...
|
|
|